Corvus Pharmaceuticals, Inc.
CRVS
Revenue
0.00
0.000.00%
-Assets
80.47M
▼-8.99M▼-10.05%
3 Months ChangeLiabilities
8.71M
▼-527.00k▼-5.71%
3 Months ChangeFree Cash Flow
-8.30M
▼-154.00k▼-1.89%
24 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-01-23
Form 8-K
ID: 0001104659-26-005968
2026-01-20
Form 8-K
ID: 0001104659-26-005035
2026-01-20
Form 8-K
ID: 0001104659-26-004795
2025-11-04
Form 10-Q
ID: 0001104659-25-106259
2025-11-04
Form 8-K
ID: 0001171843-25-006973
2025-10-02
Form 8-K
ID: 0001104659-25-096103
2025-08-07
Form 10-Q
ID: 0001558370-25-010755
2025-08-07
Form 8-K
ID: 0001171843-25-005180
2025-06-13
Form 8-K
ID: 0001171843-25-003881
2025-06-04
Form 8-K
ID: 0001171843-25-003661